Ługowski Franciszek, Babińska Julia, Awiżeń-Panufnik Zofia, Litwińska-Korcz Ewelina, Litwińska Magdalena, Ludwin Artur, Stanirowski Paweł Jan
1st Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-015 Warsaw, Poland.
Department of Obstetrics, Gynecology and Oncology, Medical University of Warsaw, 03-242 Warsaw, Poland.
J Clin Med. 2024 Nov 25;13(23):7129. doi: 10.3390/jcm13237129.
Gestational diabetes mellitus (GDM) occurs in approximately 9% of pregnancies, and proper glycemic control is of utmost importance in the prevention of GDM-associated obstetric complications. Flash glucose monitoring (FGM), a subtype of continuous glucose monitoring (CGM), offers intermittent blood glucose scanning and is considered a propitious alternative to the standard method of self-monitoring of blood glucose (SMBG). The aim of this review was to systematically assess the efficacy and acceptability of FGM in in pregnancies complicated by GDM. A systematic literature search was performed in the PubMed, MEDLINE, Scopus, and Cochrane databases. The review was conducted following the PRISMA guidelines, and the study protocol has been registered in the PROSPERO database with the registration number CRD42024545874. A total of 872 articles were initially identified, 141 publications underwent an in-depth full-text analysis, resulting in 133 studies being excluded from further assessment. Eventually, eight studies were included in the analysis. The analysis revealed that FGM is a safe and efficient method of glycemic control in GDM. The majority of the studies consider its accuracy comparable to SMBG. Furthermore, FGM is well accepted by patients with numerous advantages in user-friendliness over SMBG.
妊娠期糖尿病(GDM)约占妊娠总数的9%,适当的血糖控制对于预防GDM相关的产科并发症至关重要。实时葡萄糖监测(FGM)是连续葡萄糖监测(CGM)的一种亚型,可进行间歇性血糖扫描,被认为是自我血糖监测(SMBG)标准方法的一种有利替代方法。本综述的目的是系统评估FGM在GDM合并妊娠中的疗效和可接受性。在PubMed、MEDLINE、Scopus和Cochrane数据库中进行了系统的文献检索。本综述按照PRISMA指南进行,研究方案已在PROSPERO数据库中注册,注册号为CRD42024545874。最初共识别出872篇文章,141篇出版物进行了深入的全文分析,导致133项研究被排除在进一步评估之外。最终,8项研究纳入分析。分析表明,FGM是GDM血糖控制的一种安全有效的方法。大多数研究认为其准确性与SMBG相当。此外,FGM被患者广泛接受,在用户友好性方面比SMBG有诸多优势。